84 related articles for article (PubMed ID: 9377676)
1. [Activity of cathepsin D in some neoplasms of the gastrointestinal tract].
Kiluk M; Skrzydlewski Z; Kiluk A; Woroniecki A; Rucińska M; Kozłowski L
Pol Merkur Lekarski; 1997 May; 2(11):307-8. PubMed ID: 9377676
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients.
Szajda SD; Snarska J; Jankowska A; Roszkowska-Jakimiec W; Puchalski Z; Zwierz K
Hepatogastroenterology; 2008; 55(82-83):388-93. PubMed ID: 18613372
[TBL] [Abstract][Full Text] [Related]
3. [Cancer procoagulant and cathepsin D activity in blood serum in patients with bladder cancer].
Szajda SD; Darewicz B; Kudelski J; Chlabicz M; Domel T; Chabielska E; Skrzydlewski Z
Pol Merkur Lekarski; 2005 Jun; 18(108):651-3. PubMed ID: 16124376
[TBL] [Abstract][Full Text] [Related]
4. Cathepsin D activity in colorectal cancer.
Chabowski A; Skrzydlewska E; Sulkowska M; Famulski W; Zalewski B; Gnojnicki I; Kisielewski W
Rocz Akad Med Bialymst; 2001; 46():38-46. PubMed ID: 11780577
[TBL] [Abstract][Full Text] [Related]
5. Activity of cathepsin B and D in colorectal cancer: relationships with tumour budding.
Guzińska-Ustymowicz K; Zalewski B; Kasacka I; Piotrowski Z; Skrzydlewska E
Anticancer Res; 2004; 24(5A):2847-51. PubMed ID: 15517887
[TBL] [Abstract][Full Text] [Related]
6. [Cathepsin D activity in gastric cancer].
Kantsaliev AL; Kozyreva EA; Kushlinskiĭ NE; Rottenberg VI; Klimenkov AA; Vasil'ev AV
Vopr Onkol; 1994; 40(1-3):40-6. PubMed ID: 7701792
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic significance of cancer procoagulant activity in colorectal cancer].
Kozuszko B; Skrzydlewski Z; Famulski W
Pol Merkur Lekarski; 2000 Mar; 8(45):127-8. PubMed ID: 10870414
[TBL] [Abstract][Full Text] [Related]
8. [Significance of cathepsin B and D in physiologic and pathologic processes].
Olszewska D; Drewa T; Makarewicz R; Drewa J; Woźniak A; Maciak R
Pol Merkur Lekarski; 2001 Jan; 10(55):65-70. PubMed ID: 11320558
[TBL] [Abstract][Full Text] [Related]
9. [Proteases and prostatic disease: cytosolic cathepsin D].
Gómez Díaz ME; Ruibal-Morell A; Abascal García R
Arch Esp Urol; 2001 Mar; 54(2):101-7. PubMed ID: 11341113
[TBL] [Abstract][Full Text] [Related]
10. The clinical value of cathepsin-D and TNF-alpha in bladder cancer patients.
Salman T; el-Ahmady O; el-Shafee M; Omar S; Salman I
Anticancer Res; 1997; 17(4B):3087-90. PubMed ID: 9329608
[TBL] [Abstract][Full Text] [Related]
11. Modulation of proliferation and chemosensitivity by procathepsin D and its peptides in ovarian cancer.
Bazzett LB; Watkins CS; Gercel-Taylor C; Taylor DD
Gynecol Oncol; 1999 Aug; 74(2):181-7. PubMed ID: 10419729
[TBL] [Abstract][Full Text] [Related]
12. May cathepsin D immunoreactivity be used as a prognostic factor in endometrial carcinomas? A comparative immunohistochemical study.
Saygili U; Koyuncuoglu M; Altunyurt S; Guclu S; Uslu T; Erten O
Gynecol Oncol; 2001 Oct; 83(1):20-4. PubMed ID: 11585409
[TBL] [Abstract][Full Text] [Related]
13. Distribution of cathepsin D granules in normal and pathologic conditions in human prostate.
Islam AH; Kato H; Nishizawa O; Hayama M
Hinyokika Kiyo; 2002 Nov; 48(11):647-52. PubMed ID: 12512135
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of cathepsin D in breast cancer.
Stehle G; Wunder A; Hartung G; Sinn H; Heene DL
Br J Cancer; 1999 Dec; 81(8):1427-8. PubMed ID: 10604744
[No Abstract] [Full Text] [Related]
15. [Expression of cathepsin D in breast cancer and its clinical and histopathological correlations].
Ramírez-Ortega MC; Frías-Mendívil M; Delgado-Chávez R; Meneses-García A; Carrillo-Hernández JF; Ramírez-Ugalde MT; Zeichner-Gancz I
Rev Invest Clin; 1997; 49(5):361-8. PubMed ID: 9527695
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of cytosolyc cathepsin D content in resectable gastric cancer.
Manuel Del Casar J; Vizoso FJ; Abdel-Laa O; Sanz L; Martín A; Daniela Corte M; Bongera M; García Muñiz JL; Fueyo A
J Surg Oncol; 2004 Apr; 86(1):16-21. PubMed ID: 15048675
[TBL] [Abstract][Full Text] [Related]
17. [Serum activity of chitotriosidase, lysozyme and cathepsin H in patients with lung cancer and patients with inflammatory exudate (preliminary report)].
Gołab K; Passowicz-Muszyńska E; Jankowska R; Warwas M
Pol Merkur Lekarski; 2009 Mar; 26(153):194-7. PubMed ID: 19388531
[TBL] [Abstract][Full Text] [Related]
18. [Cathepsin D activity in human ovarian carcinoma].
Reich W; Wagner F; Hofmann KD; Marzotko F; Schmeisser G
Zentralbl Gynakol; 1984; 106(3):196-200. PubMed ID: 6702349
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density.
Lösch A; Schindl M; Kohlberger P; Lahodny J; Breitenecker G; Horvat R; Birner P
Gynecol Oncol; 2004 Feb; 92(2):545-52. PubMed ID: 14766246
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin D expression in renal cell cancer-clinical implications.
Merseburger AS; Hennenlotter J; Simon P; Ohneseit PA; Kuehs U; Kruck S; Koch E; Vogel U; Stenzl A; Kuczyk MA
Eur Urol; 2005 Sep; 48(3):519-26. PubMed ID: 16115525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
